Gamechanger!!!
Just presented at TCT and published in NEJM by @PhilGenereuxMD showing superiority of early TAVR in asymptomatic
severe AS. This trial will change the guidelines !View quoted post on X
Thomas Nestelberger
@thomas_nest
Priv. Doz. Dr. / Head of Structural Cardiology / University Hospital Basel / Switzerland
588 Following 435 Followers 783 Posts
Latest posts 5
Are you looking for a fellowship in clinical research and structural cardiology? Apply now and join our team! @FelixMahfoud @swissCTO @J_Boeddinghaus
linkedin.com/jobs/view/4000…
linkedin.com/jobs/view/4000…
First #TAVI Sapien S3 Ultra Resilia @UniSpitalBasel Switzerland in a challenging tortouos and horzontal aorta with a great result and a great team. @FelixMahfoud @swissCTO @J_Boeddinghaus Christoph Kaiser, Yves Bayard, Mohamed Bayoumi
0:45
Congratulations to this amazing work. Real world data showing great outcomes for TAVI patients in comparison with SAVR!!
🚨Most excited about the results of our industry-independent DEDICATE trial presented by @MoritzSeiffert at #ACC24 and @NEJM, impressively demonstrating non-inferior safety of #TAVI versus #SAVR in lower risk patients. ❤️🩹@dzhk_germany @UCCS_HH @UKEHamburgView quoted post on X
nejm.org/doi/full/10.10…
A new kid on the block for severe, symptomatic tricuspid regurgitation. #Triscend met it’s endpoints @TCTConference Evoque @EdwardsLifesci also got CE Mark in Europe 💪
